Intco Medical Stock Hits Day High with 4.9% Surge, Outperforming Market

Intco Medical Technology Co., Ltd. has shown significant activity today, achieving a notable gain of 4.9% on March 10, 2026. The stock reached an intraday high of CNY 51.07, reflecting strong performance metrics in the Pharmaceuticals & Biotechnology sector. Over the past year, Intco Medical has delivered an impressive return of 104.94%, significantly outperforming the China Shanghai Composite, which recorded a return of 22.49% during the same period. The company's year-to-date performance stands at 31.08%, further highlighting its robust market position. Key financial indicators reveal a positive trend for Intco Medical. The company has reported positive results for the last five consecutive quarters, with operating cash flow reaching a peak of CNY 2,119.78 million. Additionally, the return on capital employed (ROCE) is at a high of 9.77%, while raw material costs have decreased by 10.74% year-over-year. With a price-to-book ratio of 1.37 and a return on equity (ROE) of 6.76%, Intco Medical maintains an attractive valuation. The stock's performance, both in the short and long term, underscores its competitive edge within the industry.